Read + Share
Amedeo Smart
Independent Medical Education
Bowrin K, Briere JB, Fauchier L, Coleman C, et al. Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France. PLoS One 2020;15:e0225301.PMID: 31978044
Email
LinkedIn
Facebook
Twitter
Privacy Policy